WallStreetZenWallStreetZen

NASDAQ: TNGX
Tango Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Tango Therapeutics revenue was $53.81M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2026) ending on Jun 30, 2026 was $0.0, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, TNGX annual revenue was $62.4M, with 48.3% growth year-over-year.

TNGX past revenue growth

How has TNGX's revenue growth performed historically?

Company
121.47%
Industry
242.93%
Market
35.43%
TNGX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TNGX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TNGX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

TNGX revenue history

Current Revenue
$53.8M
Current Earnings
-$123.7M
Current Profit Margin
-229.9%

Be the first to know when TNGX announces revenue.

TNGX Revenue History By Year

TNGX Yearly RevenueTNGX RevenueTNGX ChangeTNGX Revenue Growth
2025-12-31$62.38M$20.32M+48.29%
2024-12-31$42.07M$5.54M+15.17%
2023-12-31$36.53M$11.67M+46.93%
2022-12-31$24.86M-$12.18M-32.89%
2021-12-31$37.04M$29.39M+383.83%
2020-12-31$7.66M-$16.99M-68.94%
2019-12-31$24.65MN/AN/A

1 of 1

Tango Therapeutics Revenue FAQ

What was TNGX's revenue last quarter?

On Aug 11, 2026, Tango Therapeutics (NASDAQ: TNGX) reported Q2 2026 revenue of $0.00 up 100% year over year. In the same quarter last year, Tango Therapeutics's revenue was $3.18 million.

What was Tango Therapeutics's revenue in 2025?

Tango Therapeutics's annual revenue for the twelve months ending Dec 31, 2025 was $62.38 million, a 48.29% increase year over year.

How much does Tango Therapeutics make in a day?

Based on Tango Therapeutics annual revenue for the past five years, TNGX makes an average of $111,168.22 per day.

What was Tango Therapeutics's annual revenue growth in the past year?

As of Q3 2026, Tango Therapeutics's revenue has grown 121.47% year over year. This is 121.46 percentage points lower than the US Biotechnology industry revenue growth rate of 242.93%. Tango Therapeutics's revenue in the past year totaled $53.81 million.

How much does Tango Therapeutics make in a year?

Tango Therapeutics's revenue by year for the past five years is:
  • Tango Therapeutics's revenue for the twelve months ending Dec 31, 2025 was $62.38 million, a 48.29% increase year over year.
  • Tango Therapeutics's annual revenue for Dec 31, 2024 was $42.07 million, a 15.17% increase from 2023.
  • Tango Therapeutics's annual revenue for 2023 was $36.53 million, a 46.93% increase from 2022.
  • Tango Therapeutics's annual revenue for 2022 was $24.86 million, a 32.89% decrease from 2021.
  • Tango Therapeutics's annual revenue for 2021 was $37.04 million, a 383.83% increase from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.